In a case that was being closely-watched by those in the legal community, a jury awarded $2 million to a woman who alleged C.R. Bard Inc. concealed information regarding the inherent flaws of its transvaginal mesh implant products.

Our Boston transvaginal mesh attorneys know that this case was the first to go to federal trial in widespread claims of flaws regarding the device.
The verdict in the case of Cisson et al v. C.R. Bard, Inc was especially welcome given that the first time around, the case resulted in a mistrial.
Continue reading
Product Liability Lawyer Blog





